The Board of Directors of Pasithea Therapeutics Corp. has authorized a buyback plan on July 20, 2023.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
7.2 USD | +4.05% | +4.05% | -2.70% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-2.70% | 7.21M | |
+8.93% | 105B | |
-0.53% | 104B | |
+5.79% | 22.94B | |
-12.75% | 22.34B | |
-7.01% | 19.25B | |
-37.08% | 17.08B | |
-8.82% | 16.96B | |
+8.06% | 14.16B | |
+39.43% | 12.63B |
- Stock Market
- Equities
- KTTA Stock
- News Pasithea Therapeutics Corp.
- Pasithea Therapeutics Corp. authorizes a Buyback Plan.